New Delhi: Genes2me, one of the leading companies in the Molecular Diagnostics space in India, has become one of the largest manufacturers of COVID-19 testing kits, with a production capacity of 9 million tests in a week. The company has delivered kits more that 40 million tests till date with the help of their full automation production facility with high throughput machines and use of technology.

Genes2Me has been able to develop these kits for COVID-19 detection in a quick turnaround time. This includes Real-Time PCR Kits, RNA Extraction Kits, VTM Kit and NGS Kits for COVID-19. These IVD kits have proven to be highly sensitive with the capability of delivering faster results without any compromise with accuracy and quality. The ViralDtect-II Real-Time PCR Kit for COVID-19 has been a game-changer which was the first Made in India Real-Time PCR Kit with superior coverage of three genes specific to SARS-COV-2. Also, the scale of IVD kit manufacturing has been ramped up to global standards which have ensured timely delivery of these kits to almost every Indian State and ICMR.

Mr. Neeraj Gupta, Founder, and CEO, Genes2me Pvt Ltd said, “At Genes2me, we pushed ourselves and increased our manufacturing capacity, particularly during the second wave. To meet the growing demand for COVID-19 testing, we expanded our output from 9 million per month to 5- 6 million per week. Our scientific and research team, logistics team, and the complete automation of our production, were all instrumental in making this feasible. We are committed to bring many more innovative, cost effective and highly sensitive testing solution in future”

Initially, our country was dependent on imported kits. COVID-19 pandemic has made us realize that India could be a global hub for manufacturing products at a very low cost without compromising on quality. Within a very short span of time, India became the largest manufacturer of gloves, masks, and IVD Testing kits. During the second wave, when there was a sudden demand for Covid-19 essentials, including testing kits, and instruments, Genes2me ramped up the production and was able to supply 5 lac tests in a day to meet the sudden demand.

Besides manufacturing IVD solutions for COVID-19, Genes2Me has worked tirelessly to bring innovative genetic testing solutions (including Instruments and Kits) for other infectious and non-infectious diseases. These testing solutions are aimed to be revolutionary, sensitive, and cost-effective for delivering results in a quick time.